REVELATION BIOSCIENCES, INC. Lease, Cost
REVELATION BIOSCIENCES, INC. (REVB) reported Lease, Cost of $122.29 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2026-02-26
- REVELATION BIOSCIENCES, INC. lease, cost for fiscal 2025 was $122.29K, a 21.29% increase from fiscal 2024.
- REVELATION BIOSCIENCES, INC. lease, cost for fiscal 2024 was $100.83K.
| Period end | Lease, Cost 12 month |
|---|---|
| 2025-12-31 | $122.29K 10-K · filed 2026-02-26 |
| 2024-12-31 | $100.83K 10-K · filed 2026-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |